Cargando…
MiR-145 inhibits EGF-induced epithelial-to-mesenchymal transition via targeting Smad2 in human glioblastoma
Background/Aims: MiR-145 and Smad2 have been widely reported in the development and progression of human malignancies. In the present study, we investigated the correlation between miR-145 and Smad2 in human glioblastoma multiforme (GBM). Methods: The epithelial–mesenchymal transition (EMT) biomarke...
Autores principales: | Chen, Weijie, Huang, Baochen, Wang, Enqin, Wang, Xingqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497881/ https://www.ncbi.nlm.nih.gov/pubmed/31114250 http://dx.doi.org/10.2147/OTT.S202129 |
Ejemplares similares
-
MiR-145 inhibits the epithelial-to-mesenchymal transition via targeting ADAM19 in human glioblastoma
por: Wang, Xingqiang, et al.
Publicado: (2017) -
The critical role of EGF-β-catenin signaling in the epithelial-mesenchymal transition in human glioblastoma
por: Wang, Xingqiang, et al.
Publicado: (2017) -
MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4
por: Hu, Jiajia, et al.
Publicado: (2012) -
Retraction: MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4
por: Hu, Jiajia, et al.
Publicado: (2013) -
Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis
por: Liu, Xiaoqiang, et al.
Publicado: (2019)